Work

Pharmacokinetic modeling and simulation (PK M&S) supported dose escalation of PF-03446962, a monoclonal antibody (mAb) against activin receptor like kinase 1, in patients with solid tumors.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.2595

Authors: Erjian Wang, Hossein Borghaei, Laura Williams Goff, Cristina Noberasco, Roger B. Cohen, Corrado Gallo Stampino, James Andrew Williams, Filippo De Braud, Jordan Berlin

Institutions: Pfizer (United States), Fox Chase Cancer Center, Vanderbilt University Medical Center, European Institute of Oncology, University of Pennsylvania, Vanderbilt University, Vanderbilt-Ingram Cancer Center

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2596819448

Cites:

Cited by:

Related to: 10